Daratumumab (anti-CD38)

Catalog No.A2027        Batch: A202701

Print

Technical Data

CAS No. 945721-28-8
Formulation PBS Buffer, PH 7.4
Isotype Human IgG1
Source Human
Storage
(From the date of receipt)
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Purity 98.74%
Protein concentration 5.09mg/ml
Endotoxin Level ≤1 EU/mg

Biological Activity

Description Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.

Selleck's Daratumumab (anti-CD38) has been cited by 1 publication

Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphoma [ J Exp Med, 2022, 219(9)e20220214] PubMed: 35881112

FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS.

Specific storage and handling information for each product is indicated on the product datasheet. Most Selleck products are stable under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage temperature. Short-term storage of many products are stable in the short-term at temperatures that differ from that required for long-term storage.
We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, follow the storage recommendations on the product data sheet.